edi048
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Apr 29, 2022 (NCT05275855)
Timeline
Indications
Mechanism of action
- PI4-kinase beta subunitINHIBITOR
PI4KB inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07249463 | Phase 2 | Nov 25, 2025 | Novartis |
| NCT05275855 | Phase 1 | Apr 29, 2022 | Novartis |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Novartis | For profit | 2 | 2 | 2 | 2022 |
1 organizations
Page 1 / 1